The effects of acute treatment with paroxetine, amitriptyline, and placebo on driving performance and cognitive function in healthy Japanese subjects: A double-blind crossover trial

Human Psychopharmacology

Volumn 23, Issue 5, 2008, Pages 399-407

  Iwamoto, Kunihiro ^a   Takahashi, Masahiro ^a   Nakamura, Yukako ^a   Kawamura, Yukiko ^b   Ishihara, Ryoko ^a   Uchiyama, Yuji ^c   Ebe, Kazutoshi ^c   Noda, Akiko ^d   Noda, Yukihiro ^b   Yoshida, Keizo ^a   Iidaka, Tetsuya ^a   Ozakir, Norio ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MEIJO UNIVERSITY   (Japan)

^c Rd Management Section   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

Amitriptyline; Antidepressants; Cognitive function; Driving performance; Paroxetine

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; PAROXETINE; PLACEBO; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ALERTNESS; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRIVING ABILITY; DRUG EFFECT; FATIGUE; HUMAN; HUMAN EXPERIMENT; JAPANESE; MALE; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SIDE EFFECT; SIMULATION; SINGLE DRUG DOSE; SOMNOLENCE; TASK PERFORMANCE; TRAFFIC ACCIDENT; WISCONSIN CARD SORTING TEST; XEROSTOMIA; ASIAN; CAR DRIVING; COMPARATIVE STUDY; JAPAN; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; REACTION TIME;

ADULT; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOMOBILE DRIVING; COGNITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; JAPAN; MALE; PAROXETINE; PSYCHOMOTOR PERFORMANCE; REACTION TIME;

EID: 48249122707     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.939     Document Type: Article

References (41)

1. Anderson IM. 2000. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 58: 19-36.
2. Brookhuis K, de Waard D, Mulder B. 1994. Measuring driving performance by car-following in traffic. Ergonomics 37: 427-434.
3. Brunnauer A, Laux G, Geiger E, Soyka M, Moller HJ. 2006. Antidepressants and driving ability: results from a clinical study. J Clin Psychiatry 67: 1776-1781.
4. Bye C, Clubley M, Peck AW. 1978. Drowsiness, impaired performance and tricyclic antidepressants drugs. Br J Clin Pharmacol 6: 155-162.
5. Callicott JH, Bertolino A, Mattay VS, et al. 2000. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex 10: 1078-1092.
6. Callicott JH, Egan MF, Mattay VS, et al. 2003. Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. Am J Psychiatry 160: 709-719.
7. Comblatt BA, Risch NJ, Faris G, Friedman D, Erlenmeyer-Kimling L. 1988. The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Res 26: 223-238.
8. Crome P, Newman B. 1978. A comparison of the effects of single doses of mianserin and amitriptyline on psychomotor tests in normal volunteers. J Int Med Res 6: 430-434.
9. Geddes JR, Carney SM, Davies C, et al. 2003. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 361: 653-661.
10. Hampson E. 1990. Variations in sex-related cognitive abilities across the menstrual cycle. Brain Cogn 14: 26-43.
11. Heaton RK. 1981. The Wisconsin Card Sorting Test (Manual). Psychological Assessment Resources: Odessa, Fl.
12. Hindmarch I, Subhan Z, Stoker MJ. 1983. The effects of zimeldine and amitriptyline on car driving and psychomotor performance. Acta Psychiatr Scand Suppl 308: 141-146.
13. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC. 1973. Quantification of sleepiness: a new approach. Psychophysiology 10: 431-436.
14. Kashima H, Honda T, Kato M, et al. 1987. Neuropsychological investigation on chronic schizophrenia-aspect of its frontal functions. In Cerebral Dynamics, Laterality and Psychopathology, Takahashi R, Flor-Henry P, Gruzelier J, Niwa S (eds), Elsevier: Amsterdam.
15. Kerr JS, Powell J, Hindmarch I. 1996. The effects of reboxetine and amitriptyline, with and without alcohol on cognitive function and psychomotor performance. Br J Clin Pharmacol 42: 239-241.
16. Kinirons MT, Jackson SH, Kalra L, Trevit RT, Swift CG. 1993. Computerised psychomotor performance testing: a comparative study of the single dose pharmacodynamics of minaprine and amitriptyline in young and elderly subjects. Br J Clin Pharmacol 36: 376-379.
17. Leveille SG, Buchner DM, Koepsell TD, McCloskey LW, Wolf ME, Wagner EH. 1994. Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology 5: 591-598.
18. Maki PM, Rich JB, Rosenbaum RS. 2002. Implicit memory varies across the menstrual cycle: estrogen effects in young women. Neuropsychologia 40: 518-529.
19. Nathan PJ, Sitaram G, Stough C, Silberstein RB, Sali A. 2000. Serotonin, noradrenaline and cognitive function: a preliminary investigation of the acute pharmacodynamic effects of a serotonin versus a serotonin and noradrenaline reuptake inhibitor. Behav Pharmacol 11: 639-642.
20. National Highway Traffic Safety Administration, U. S. Department of Transportation, 2007. Traffic Safety Facts 2005, Washington DC.
21. National Police Agency Transportation Authority, 2007. Generation Status of Traffic Accidents During the 18-years of the Heisei Era, Tokyo.
22. Nemeroff CB. 2003. Improving antidepressant adherence. J Clin Psychiatry, 64: (Suppl. 18): 25-30.
23. Ogura C, Kishimoto A, Mizukawa R, et al. 1983. Influence of single doses of dothiepin and amitriptyline on physiological measures and psychomotor performance in normal young and elderly volunteers. Neuropsychobiology 10: 103-107.
24. O'Hanlon JF. 1984. Driving performance under the influence of drugs: rationale for, and application of, a new test. Br J Clin Pharmacol 18 (Suppl. 1): 121S-129S.
25. O'Hanlon JF, Haak TW, Blaauw GJ, Riemersma JB. 1982. Diazepam impairs lateral position control in highway driving. Science 217: 79-81.
26. Peck AW, Bye CE, Clubley M, Henson T, Riddington C. 1979. A comparison of bupropion hydrochloride with dexamphetamine and amitriptyline in healthy subjects. Br J Clin Pharmacol 7: 469-478.
27. Phillips SM, Sherwin BB. 1992. Variations in memory function and sex steroid hormones across the menstrual cycle. Psychoneuroendocrinology 17: 497-506.
28. Ramaekers JG. 2003. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test. J Clin Psychiatry 64: 20-29.
29. Ramaekers G, Lamers J, Verhey F, et al. 2002. A comparative study of the effects of carbamazepine and the NMDA receptor antagonist remacemide on road tracking and car-following performance in actual traffic. Psychopharmacology (Berl) 159: 203-210.
30. Ramaekers JG, Muntjewerff ND, O'Hanlon JF. 1995. A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance. Br J Clin Pharmacol 39: 397-404.
31. Ray WA, Fought RL, Decker MD. 1992. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 136: 873-883.
32. Richardson JS, Keegan DL, Bowen RC, et al. 1994. Verbal learning by major depressive disorder patients during treatment with fluoxetine or amitriptyline. Int Clin Psychopharmacol 9: 35-40.
33. Ridout F, Hindmarch I. 2001. Effects of tianeptine and mianserin on car driving skills. Psychopharmacology (Berl) 154: 356-361.
34. Ridout F, Meadows R, Johnsen S, Hindmarch I. 2003. A placebo controlled investigation into the effects of paroxetine and mirtazapine on measures related to car driving performance. Hum Psychopharmacol 18: 261-269.
35. Robbe HW, O'Hanlon JF. 1995. Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers. Eur Neuropsychopharmacol 5: 35-42.
36. Tiller JW. 1990. Antidepressants, alcohol and psychomotor performance. Acta Psychiatr Scand Suppl 360: 13-17.
37. Uchiyama Y, Ebe K, Kozato A, Okada T, Sadato N. 2003. The neural substrates of driving at a safe distance: a functional MRI study. Neurosci Lett 352: 199-202.
38. van Laar MW, van Willigenburg AP, Volkerts ER. 1995. Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects. J Clin Psychopharmacol 15: 30-40.
39. van Laar MW, Volkerts ER, Verbaten MN, Trooster S, van Megen HJ, Kenemans JL. 2002. Differential effects of amitriptyline, nefazodone and paroxetine on performance and brain indices of visual selective attention and working memory. Psychopharmacology (Berl) 162: 351-363.
40. Wingen M, Bothmer J, Langer S, Ramaekers JG. 2005. Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial. J Clin Psychiatry 66: 436-443.
41. Wingen M, Ramaekers JG, Schmitt JA. 2006. Driving impairment in depressed patients receiving long-term antidepressant treatment. Psychopharmacology (Berl) 188: 84-91.